Blog

As trials continue to increase in complexities, sites and sponsors must work together to minimize deviations and cause for FDA findings.

Staff turnover can greatly impact the quality and progress of an organization’s clinical trials and research projects.

More than two decades ago, we created OnCore CTMS. What do we have in store for the future?

Discover the crucial role of a customized QMS in streamlining and optimizing study startup processes.

A phased approach to quality management systems (QMS) ensures quality is embedded at every stage, from discovery to post study.

Ensure safe transport of investigational products with meticulous planning and rigorous procedures to mitigate hazards and uphold biosafety.

Clinical research professionals provide relevant insights into challenges and barriers impeding study start up.

Learn how robust financial practices and a CTMS aligned with GAAP principles can drive sustainable growth and efficiency within an organization.

A robust corrective and preventive action (CAPA) stands as a critical tool for proactively addressing deviations in clinical research.

Understand the significance of HRPP staffing despite an sIRB mandate, and how HRPP staffing maintains ethical research practices.

In a complex clinical trial, data monitoring committees oversee interim data to ensure adequate safety monitoring.

Uncover key regulations and insights regarding GxP in pharmaceuticals, medical devices, and clinical research.